Literature DB >> 22738276

Increase in incidence of adult T-cell leukemia/lymphoma in non-endemic areas of Japan and the United States.

Dai Chihara1, Hidemi Ito, Kota Katanoda, Akiko Shibata, Tomohiro Matsuda, Kazuo Tajima, Tomotaka Sobue, Keitaro Matsuo.   

Abstract

Adult T-cell leukemia/lymphoma (ATLL) is a peripheral T cell neoplasm that is associated with infection by the human T-cell leukemia virus type I (HTLV-1). Although the high incidence of ATLL in HTLV-1-endemic areas is well known, population-based evidence concerning the incidence of ATLL in non-endemic areas is scarce. To answer this, we estimated the age-standardized incidence of ATLL from 1993 to 2006 for Japan and 1993 to 2008 for the US and assessed its trend using data from a population-based cancer registry in Japan and Surveillance Epidemiology and End Results (SEER) in the US. The Japanese data were collected from 15 prefectures. A total of 2055 patients in the three prefectures in Kyushu and 1380 patients in the 12 prefectures in Honshu were diagnosed with ATLL in the study period. In the US, a total of 140 patients were diagnosed with ATLL. The results showed that the age-standardized incidence in non-endemic areas in Japan and in the US significantly increased during this period (annual percent change [95%CI]; Japan-Honshu: +4.6% [1.1, 8.2]; US: +6.2% [1.5, 11.1]), while in the endemic areas of Japan there was no change (annual percent change [95%CI]; Japan-Kyushu: 0.0% [-1.6, 1.7]). This result indicates that the disease has been spread by carriers to non-endemic areas, and suggests the necessity of establishing a standard preventive strategy.
© 2012 Japanese Cancer Association.

Entities:  

Mesh:

Year:  2012        PMID: 22738276     DOI: 10.1111/j.1349-7006.2012.02373.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  14 in total

Review 1.  Incidence of adult T-cell leukemia/lymphoma in nonendemic areas.

Authors:  Noriaki Yoshida; Dai Chihara
Journal:  Curr Treat Options Oncol       Date:  2015-02

2.  Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma-not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry.

Authors:  Shigeo Fuji; Shuhei Kida; Kayo Nakata; Toshitaka Morishima; Isao Miyashiro; Jun Ishikawa
Journal:  Ann Hematol       Date:  2020-10-21       Impact factor: 3.673

3.  A rare case of adult T cell leukemia/lymphoma: clinicopathological correlation with autopsy confirmation.

Authors:  M G Manoj; J Kotwal; V Dutta
Journal:  Indian J Hematol Blood Transfus       Date:  2012-11-21       Impact factor: 0.900

4.  North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies.

Authors:  Urvi A Shah; Elaine Y Chung; Orsi Giricz; Kith Pradhan; Keisuke Kataoka; Shanisha Gordon-Mitchell; Tushar D Bhagat; Yun Mai; Yongqiang Wei; Elise Ishida; Gaurav S Choudhary; Ancy Joseph; Ronald Rice; Nadege Gitego; Crystall Parrish; Matthias Bartenstein; Swati Goel; Ioannis Mantzaris; Aditi Shastri; Olga Derman; Adam Binder; Kira Gritsman; Noah Kornblum; Ira Braunschweig; Chirag Bhagat; Jeff Hall; Armin Graber; Lee Ratner; Yanhua Wang; Seishi Ogawa; Amit Verma; B Hilda Ye; Murali Janakiram
Journal:  Blood       Date:  2018-08-13       Impact factor: 22.113

Review 5.  Recent advances in the treatment of adult T-cell leukemia-lymphomas.

Authors:  Atae Utsunomiya; Ilseung Choi; Dai Chihara; Masao Seto
Journal:  Cancer Sci       Date:  2015-03-06       Impact factor: 6.716

6.  Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report.

Authors:  Lucy B Cook; Shigeo Fuji; Olivier Hermine; Ali Bazarbachi; Juan Carlos Ramos; Lee Ratner; Steve Horwitz; Paul Fields; Alina Tanase; Horia Bumbea; Kate Cwynarski; Graham Taylor; Thomas A Waldmann; Achilea Bittencourt; Ambroise Marcais; Felipe Suarez; David Sibon; Adrienne Phillips; Matthew Lunning; Reza Farid; Yoshitaka Imaizumi; Ilseung Choi; Takashi Ishida; Kenji Ishitsuka; Takuya Fukushima; Kaoru Uchimaru; Akifumi Takaori-Kondo; Yoshiki Tokura; Atae Utsunomiya; Masao Matsuoka; Kunihiro Tsukasaki; Toshiki Watanabe
Journal:  J Clin Oncol       Date:  2019-01-18       Impact factor: 44.544

7.  Clinicopathological analysis of sinonasal malignant lymphoma in an HTLV-1 endemic area in Japan -special focus on primary sinonasal diffuse large B-cell lymphoma.

Authors:  Daisuke Murakami; Kaname Miyashita; Tetsuya Koyama; Hirofumi Omori; Yusuke Miyamoto; Motohiro Sawatsubashi; Takashi Nakagawa
Journal:  J Clin Exp Hematop       Date:  2019-08-08

8.  Targeting NF-κB with Nanotherapy in a Mouse Model of Adult T-Cell Leukemia/Lymphoma.

Authors:  Daniel A Rauch; John C Harding; Lee Ratner; Samuel A Wickline; Hua Pan
Journal:  Nanomaterials (Basel)       Date:  2021-06-16       Impact factor: 5.076

9.  Association between decreasing trend in the mortality of adult T-cell leukemia/lymphoma and allogeneic hematopoietic stem cell transplants in Japan: analysis of Japanese vital statistics and Japan Society for Hematopoietic Cell Transplantation (JSHCT).

Authors:  D Chihara; H Ito; T Matsuda; K Katanoda; A Shibata; S Taniguchi; A Utsunomiya; T Sobue; K Matsuo
Journal:  Blood Cancer J       Date:  2013-11-15       Impact factor: 11.037

Review 10.  Epidemiology of HTLV-1 Infection and ATL in Japan: An Update.

Authors:  Masako Iwanaga
Journal:  Front Microbiol       Date:  2020-05-29       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.